Compare MLGO & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLGO | COCH |
|---|---|---|
| Founded | 2018 | 1995 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Blank Checks |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.9M | 51.0M |
| IPO Year | 2020 | 2021 |
| Metric | MLGO | COCH |
|---|---|---|
| Price | $3.40 | $0.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 42.1K | ★ 50.4K |
| Earning Date | 04-01-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.45 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $87,132,230.00 | $241,000.00 |
| Revenue This Year | N/A | $1.58 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.91 | ★ N/A |
| Revenue Growth | 6.21 | ★ 7.11 |
| 52 Week Low | $3.02 | $0.36 |
| 52 Week High | $11.47 | $1.89 |
| Indicator | MLGO | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 37.47 | N/A |
| Support Level | $3.30 | N/A |
| Resistance Level | $4.42 | N/A |
| Average True Range (ATR) | 0.20 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 21.28 | 0.00 |
MicroAlgo Inc is engaged in the development and application of bespoke central processing algorithms and provides solutions by integrating these algorithms with software or hardware, or both, to streamline digital services. Its services include algorithm optimization, accelerating computing power without hardware upgrades, lightweight data processing, and data intelligence services. Its technology and solutions are mainly in internet multimedia video advertising, where it provides advertising distribution solutions, software services, comprehensive solutions for enterprise customers, and intelligent chips solutions. It derives revenue from central processing algorithm services for internet advertisement and intelligent chips and services, with maximum revenue generated from Mainland PRC.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.